NEW YORK (GenomeWeb News) – Agilent Technologies and Singapore's Temasek Polytechnic announced on Tuesday a collaboration aimed at product safety testing.

The two have created a new laboratory called the Temasek Polytechnic-Agilent Partner Lab, which will help small and mid-sized enterprises in Singapore maintain safety and quality standards. In particular, bioanalytical tools from Agilent and resources at Temasek Polytechnic will be leveraged to help businesses that develop, manufacture, or distribute traditional Chinese medicine and food products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.